Al-Shammri S, Chattopadhyay A, Raghupathy R (2025) Vitamin D supplementation mediates a shift toward anti-inflammatory cytokine response in multiple sclerosis. Med Princ Pract. https://doi.org/10.1159/000544106
PubMed PubMed Central Google Scholar
Álvarez-Luquín DD, Arce-Sillas A, Leyva-Hernández J, Sevilla-Reyes E, Boll MC, Montes-Moratilla E, Vivas-Almazán V, Pérez-Correa C, Rodríguez-Ortiz U, Espinoza-Cárdenas R (2019) Regulatory impairment in untreated Parkinson’s disease is not restricted to Tregs: other regulatory populations are also involved. J Neuroinflammation 16:1–11
An J, Fu D, Chen X, Guan C, Li L, Bai J, Lv H (2025) Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation? Front Immunol 15:1498288
PubMed PubMed Central Google Scholar
Andreadou M, Ingelfinger F, De Feo D, Cramer TLM, Tuzlak S, Friebel E, Schreiner B, Eede P, Schneeberger S, Geesdorf M, Ridder F, Welsh CA, Power L, Kirschenbaum D, Tyagarajan SK, Greter M, Heppner FL, Mundt S, Becher B (2023) IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice. Nat Neurosci 26(10):1701–1712
CAS PubMed PubMed Central Google Scholar
Andres-Martin F, James C, Catalfamo M (2024) IL-27 expression regulation and its effects on adaptive immunity against viruses. Front Immunol 15:1395921
CAS PubMed PubMed Central Google Scholar
Ano Y, Ikado K, Uchida K, Nakayama H (2020) Amyloid β-induced mesenteric inflammation in an Alzheimer’s disease transgenic mouse model. Curr Alzheimer Res 17(1):52–59
Avarachan J, Augustine A, Shinde PM, Gunasekaran V (2021) A mechanistic approach of peroxisome proliferator-activated receptors and its subtypes on clinical and preclinical model of neurodegenerative disorders. Res J Pharm Technol 14(7):3967–3975
Barac IS, Văcăraș V, Iancu M, Mureșanu DF, Procopciuc LM (2023a) Interleukins (IL-23 and IL-27) serum levels: relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate. Heliyon. https://doi.org/10.1016/j.heliyon.2023.e17427
PubMed PubMed Central Google Scholar
Barac IS, Văcăraș V, Iancu M, Mureșanu DF, Procopciuc LM (2023b) Interleukins (IL-23 and IL-27) serum levels: relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate. Heliyon 9(6):e17427
CAS PubMed PubMed Central Google Scholar
Bastian D, Wu Y, Betts BC, Yu X-Z (2019) The IL-12 cytokine and receptor family in graft-vs.-host disease. Front Immunol 10:988
CAS PubMed PubMed Central Google Scholar
Beckers L, Baeten P, Popescu V, Swinnen D, Cardilli A, Hamad I, Van Wijmeersch B, Tavernier SJ, Kleinewietfeld M, Broux B, Fraussen J, Somers V (2024) Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab. Clin Immunol 259:109894
Benarroch E (2024) What is the role of cytokines in synaptic transmission? Neurology 103(8):e209928
Bhardwaj V, Kumari S, Dhapola R, Sharma P, Beura SK, Singh SK, Vellingiri B, HariKrishnaReddy D (2025) Shedding light on microglial dysregulation in Alzheimer’s disease: exploring molecular mechanisms and therapeutic avenues. Inflammopharmacology 33(2):679–702
Bourgonje AR, Ungaro RC, Mehandru S, Colombel JF (2024) Targeting the IL-23 pathway in inflammatory bowel disease. Gastroenterology 168(1):29–52
Bright F, Werry EL, Dobson-Stone C, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kassiou M (2019) Neuroinflammation in frontotemporal dementia. Nat Rev Neurol 15(9):540–555
Cassatella MA, Gardiman E, Arruda-Silva F, Bianchetto-Aguilera F, Gasperini S, Bugatti M, Vermi W, Larousserie F, Devergne O, Tamassia N (2020) Human neutrophils activated by TLR8 agonists, with or without IFNγ, synthesize and release EBI3, but not IL-12, IL-27, IL-35, or IL-39. J Leukoc Biol 108(5):1515–1526
Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S, Lucian L, Geissler R, Brodie S, Kimball AB (2006) IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med 203(12):2577–2587
CAS PubMed PubMed Central Google Scholar
Chen Z, Balachandran YL, Chong WP, Chan KW (2024) Roles of cytokines in Alzheimer’s disease. Int J Mol Sci 25(11):5803
CAS PubMed PubMed Central Google Scholar
Choi JK, Egwuagu CE (2021) Interleukin 35 regulatory B cells. J Mol Biol 433(1):166607
Choi J, Leung PS, Bowlus C, Gershwin ME (2015) IL-35 and autoimmunity: a comprehensive perspective. Clin Rev Allergy Immunol 49:327–332
Chu M, Wen L, Jiang D, Liu L, Nan H, Yue A, Wang Y, Wang Y, Qu M, Wang N (2023) Peripheral inflammation in behavioural variant frontotemporal dementia: associations with central degeneration and clinical measures. J Neuroinflammation 20(1):65
PubMed PubMed Central Google Scholar
Clénet ML, Laurent C, Lemaitre F, Farzam-kia N, Tastet O, Devergne O, Lahav B, Girard M, Duquette P, Prat A (2021) The IL-27/IL-27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients. Clin Trans Immunol 10(3):e1262
Collison LW, Vignali DA (2008) Interleukin-35: odd one out or part of the family? Immunol Rev 226(1):248–262
CAS PubMed PubMed Central Google Scholar
Dias de Sousa MA, Desidério CS, da Silva Catarino J, Trevisan RO, Alves da Silva DA, Rocha VFR, Bovi WG, Timoteo RP, Bonatti RCF, da Silva AE (2022) Role of cytokines, chemokines and IFN-γ+ IL-17+ double-positive CD4+ T cells in patients with multiple sclerosis. Biomedicines 10(9):2062
CAS PubMed PubMed Central Google Scholar
Dong C, Tan D, Sun H, Li Z, Zhang L, Zheng Y, Liu S, Zhang Y, He Q (2024) Interleukin-12 delivery strategies and advances in tumor immunotherapy. Curr Issues Mol Biol 46(10):11548–11579
CAS PubMed PubMed Central Google Scholar
Duffy, S. (2018). The role of regulatory T cells and interleukin-35 in pain associated with an animal model of multiple sclerosis, UNSW Sydney
Dzamko N (2023) Cytokine activity in Parkinson’s disease. Neuronal Signaling. https://doi.org/10.1042/NS20220063
PubMed PubMed Central Google Scholar
Eede P, Obst J, Benke E, Yvon-Durocher G, Richard BC, Gimber N, Schmoranzer J, Böddrich A, Wanker EE, Prokop S (2020) Interleukin-12/23 deficiency differentially affects pathology in male and female Alzheimer’s disease-like mice. EMBO Rep 21(3):e48530
CAS PubMed PubMed Central Google Scholar
Ellrichmann G, Reick C, Saft C, Linker RA (2013) The role of the immune system in Huntington’s disease. J Immunol Res 2013(1):541259
Erichsen PA, Henriksen EE, Nielsen JE, Ejlerskov P, Simonsen AH, Toft A (2025) Immunological fluid biomarkers in frontotemporal dementia: a systematic review. Biomolecules 15(4):473
CAS PubMed PubMed Central Google Scholar
Fu J, Huang Y, Bao T, Liu C, Liu X, Chen X (2022) The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A. J Neuroinflammation 19(1):98
CAS PubMed PubMed Central Google Scholar
Gaimari A, Fusaroli M, Raschi E, Baldin E, Vignatelli L, Nonino F, De Ponti F, Mandrioli J, Poluzzi E (2022) Amyotrophic lateral sclerosis as an adverse drug reaction: a disproportionality analysis of the food and drug administration adverse event reporting system. Drug Saf 45(6):663–673
Gałecka M, Bliźniewska-Kowalska K, Orzechowska A, Szemraj J, Maes M, Berk M, Su K-P, Gałecki P (2021) Inflammatory versus anti-inflammatory profiles in major depressive disorders—the role of IL-17, IL-21, IL-23, IL-35 and Foxp3. J Pers Med 11(2):66
PubMed PubMed Central Google Scholar
Gao H, Li K, Ai K, Geng M, Cao Y, Wang D, Yang J, Wei X (2023) Interleukin-12 induces IFN-γ secretion and STAT signaling implying its potential regulation of Th1 cell response in Nile tilapia. Fish Shellfish Immunol 140:108974
García-Domínguez M (2025) The role of IL-23 in the development of inflammatory diseases. Biol 14(4):347
Gautam AS, Pulivarthi Cb, Singh RK (2023) Proinflammatory IL-17 levels in serum/cerebrospinal fluid of patients with neurodegenerative diseases: a meta-analysis study. Naunyn Schmiedebergs Arch Pharmacol 396(3):577–588
Gaviglio EA, Peralta Ramos JM, Arroyo DS, Bussi C, Iribarren P, Rodriguez-Galan MC (2022a) Systemic sterile induced-co-expression of IL-12 and IL-18 drive IFN-γ-dependent activation of microglia and recruitment of MHC-II-expressing inflammatory monocytes into the brain. Int Immunopharmacol 105:108546
Comments (0)